The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation
Open accessAbstract
Deferoxamine is widely used therapeutically as a chelator of ferric ion in disorders of iron overload. This study demonstrates that this drug is a potent inhibitor of DNA synthesis by human B and T lymphocytes in vitro, but has relatively little effect on the synthesis of RNA and protein. The inhibitory effects of deferoxamine are completely reversible by washing or by adding stoichiometric amounts of Fe3+. Micromolar concentrations of deferoxamine decrease intracellular levels of deoxyribonucleoside triphosphates, which is similar to the effects of hydroxyurea. The binding of iron by deferoxamine likely causes an inhibition of ribonucleotide reductase activity, thereby preventing cells from completing the S phase of the cell proliferation cycle. As a reversible and nontoxic S-phase inhibitor, it may have important experimental and therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 612
Ribonucleotide Reductase—a Radical Enzyme
Reichard, P., & Ehrenberg, A. (1983) · Science · doi:10.1126/science.6306767 · Cited by 423
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human Cells
Hoffbrand, A. V., Ganeshaguru, K., Hooton, J. W. L., & Tattersall, M. H. N. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03570.x · Cited by 241
Survival and desferrioxamine in thalassaemia major.
Modell, B., Letsky, E. A., Flynn, D. M., Peto, R., & Weatherall, D. J. (1982) · BMJ · doi:10.1136/bmj.284.6322.1081 · Cited by 206
Thelander, L., Gräslund, A., & Thelander, M. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91040-9 · Cited by 182
Cohen, A., Barankiewicz, J., Lederman, H. M., & Gelfand, E. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44179-2 · Cited by 139
Self-citationIRON: ITS INTRACELLULAR LOCALIZATION AND POSSIBLE ROLE IN CELL DIVISION
Robbins, E., & Pederson, T. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.4.1244 · Cited by 134
Characterization of a mutator gene in Chinese hamster ovary cells.
Meuth, M., L'Heureux-Huard, N., & Trudel, M. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6505 · Cited by 117
Cited by
The importance of free radicals and catalytic metal ions in human diseases.
Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941
The roles of iron in health and disease
Lieu, P. T., Heiskala, M., Peterson, P. A., & Yang, Y. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 804
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
Olivieri, N. F., Buncic, J. R., Chew, E., Gallant, T., Harrison, R. V., Keenan, N., Logan, W., Mitchell, D., Ricci, G., Skarf, B., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141402 · Cited by 429
Self-citationYu, Y., Kalinowski, D. S., Kovacevic, Z., Siafakas, A. R., Jansson, P. J., Stefani, C., Lovejoy, D. B., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900552r · Cited by 397
Metadata
- Authors
- Lederman, H., Cohen, A., Lee, J., Freedman, M., & Gelfand, E.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1984-09-01
- Volume
- 64
- Issue
- 3
- Pages
- 748-753
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2346520058
- Cited by
- 282
- References
- 14
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. https://app.cochat.ai/papers/10.1182/blood.v64.3.748.748
- The paper
- Lederman, H., Cohen, A., Lee, J., Freedman, M., & Gelfand, E. (1984). Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood. https://doi.org/10.1182/blood.v64.3.748.748
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.